Methinks AI is redefining stroke care through fast, accessible, and scalable AI-driven imaging. We specialize in non-contrast CT (NCCT) — the most widely available imaging — to detect large vessel occlusions and intracerebral hemorrhages, enabling earlier triage and faster treatment decisions.



Integrated into Microsoft Teams and in partnership with Microsoft, Methinks is built for clinical coordination and technical scalability. Our solution is CE-marked, validated in top hospitals across Europe and the U.S., and is transforming stroke pathways in both high- and low-resource settings.



A VC-backed, commercial-stage company, Methinks is proud to partner with Medtronic to expand access to stroke care across CEMA, and to power the Done Symple international trial focused on late-window stroke treatment.



We’re commited to building AI to expand treatment access — empowering teams to make faster decisions and reach more patients, when every minute matters.